Biotrin Intl to develop a nucleic acid test (NAT) analyser

Friday, 17 June, 2011 | Supplied by: DiaSorin Australia Pty Ltd


DiaSorin has announced that its fully owned Irish subsidiary Biotrin International has signed an agreement with Precision System Science (PSS) of Japan for the development of a nucleic acid test (NAT) analyser.

PSS is a provider of laboratory instruments for nucleic acid extraction and amplification and has several years of experience in the development and production for third parties of automated instruments in the field of molecular diagnostic. According to this agreement, PSS will develop the first-generation analyser to be used in conjunction with a panel of nucleic acid tests in the clinical area of infectious disease which are in development at Biotrin using the LAMP technology.

Biotrin is the DiaSorin centre for the development and manufacture of molecular diagnostics products using the LAMP (loop mediated isothermal amplification) technology, licensed from Eiken Chemical Company. The first panel of applications will be in the field of infectious disease and onco-haematology and will complement DiaSorin’s current extensive Liaison product offering in the field of immunodiagnostics. The commercial launch is expected to happen in the second half of next year.

Online: www.diasorin.com
Phone: 02 9338 4888
Related Products

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...

Azure Biosystems Ao Microplate Reader

The 96-well Ao Microplate Reader from Azure Biosystems offers a multitude of features to help...

Navinci Naveni Plex isPLA multiplex solution

The isPLA multiplex solution is designed to simultaneously detect PD1/PD-L1 interactions...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd